A pharmaceutical company engaged in generics, new drugs and healthcare products, with a portfolio of 300 products delivering transformative treatments for patients. Its offerings span intermediates, APIs and finished dosage forms for technology transfer and commercialization, with a current focus on out-licensing, particularly in oncology, UDCA, MDI and DPI.
No hay comentarios disponibles.
Deja tu valoración & comentario